Showing results (201-210 of 339) with videos related to
Sort By:
Pageof 34
British Journal of Haematology|August 16, 2025
Has early mortality following single-unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in JapanTakaaki Konuma, Junya Kanda, Naoyuki Uchida, et al.Bone Marrow Transplantation|May 23, 2024
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignanciesSatoshi Kaito, Yuho Najima, Daichi Sadato, et al.Bone Marrow Transplantation|May 7, 2024
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular TherapyHidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, et al.American Journal of Hematology|July 26, 2023
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide studyShigeki Hirabayashi, Tadakazu Kondo, Satoshi Nishiwaki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis]Shuhei Kurosawa, Noriko Doki, Satoshi Kaito, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)]Atsushi Wada, Noriko Doki, Yuki Otsuka, et al.Transplantation and Cellular Therapy|September 5, 2025
Risk Stratification Using DIPSS and Splenomegaly in Myelofibrosis Treated with Pre-Transplant JAK inhibitorsYosuke Okada, Kazuki Sakatoku, Shuichi Shirane, et al.Cytotherapy|June 21, 2022
Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patientsTomoyasu Jo, Yasuyuki Arai, Tadakazu Kondo, et al.Cytotherapy|November 6, 2024
Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndromeAtsushi Marumo, Yasunobu Nagata, Machiko Fujioka, et al.Bone Marrow Transplantation|July 13, 2023
External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemiaMasamitsu Yanada, Yoshimitsu Shimomura, Shohei Mizuno, et al.Pageof 34